Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bovie Medical Corp (BVX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2018 Financial Results on March 13, 2019

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical...

APYX : 6.90 (+7.81%)
BVX : 6.48 (+1.09%)
Apyx Medical Corporation Reports Preliminary Full Year and Fourth Quarter 2018 Revenue Results

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical...

APYX : 6.90 (+7.81%)
BVX : 6.48 (+1.09%)
Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan

Conatus (CNAT) concentrates on the development of its lead candidate emricasan for treating patients with fibrosis or cirrhosis caused by NASH.

CNAT : 1.89 (+0.53%)
BVX : 6.48 (+1.09%)
NVS : 90.88 (+0.41%)
PFE : 43.03 (+2.11%)
Has Bovie Medical (BVX) Outpaced Other Medical Stocks This Year?

Is (BVX) Outperforming Other Medical Stocks This Year?

BVX : 6.48 (+1.09%)
Bovie Medical Corporation Files 510(k) Submission with the FDA for a New Indication to Market and Sell J-Plasma/Renuvion for Use in Dermal Resurfacing Procedures

Bovie Medical Corporation (NYSE:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under the Renuvion(R)...

BVX : 6.48 (+1.09%)
Bovie Medical Corporation Announces Appointment of Tara H. Semb as Chief Financial Officer

Bovie Medical Corporation (NYSE:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under the Renuvion(R)...

BVX : 6.48 (+1.09%)
Bovie Medical Corporation Announces Corporate Name Change to Apyx Medical Corporation and Plans to Transition Common Stock Listing to NASDAQ Global Select Market

Bovie Medical Corporation (NYSE:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under the Renuvion(R)...

SSRG : 13.18 (+0.38%)
BVX : 6.48 (+1.09%)
Quidel (QDEL) Catches Eye: Stock Jumps 6.7%

Quidel (QDEL) shares rose nearly 7% in the last trading session, amid huge volumes.

BVX : 6.48 (+1.09%)
QDEL : 67.70 (+0.79%)
Why Varex Imaging (VREX) Could Be Positioned for a Slump

Varex Imaging (VREX) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

BVX : 6.48 (+1.09%)
VREX : 32.57 (+0.34%)
Conatus' Emricasan Misses Primary Endpoint in Mid-Stage Study

Conatus' (CNAT) emricasan fails to meet the primary endpoint in a phase IIb study on compensated NASH cirrhosis patients at high risk of decompensation.

CNAT : 1.89 (+0.53%)
BVX : 6.48 (+1.09%)
NVS : 90.88 (+0.41%)
PFE : 43.03 (+2.11%)
Will Bovie Medical (BVX) Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Bovie Medical Corporation (BVX).

BVX : 6.48 (+1.09%)
Detailed Research: Economic Perspectives on Plains Group Holdings, Vericel, LGL Group, Bovie Medical, eGain, and Navios Maritime Acquisition -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Plains Group Holdings, L.P....

LGL : 7.03 (+1.93%)
NNA : 7.60 (-1.04%)
BVX : 6.48 (+1.09%)
VCEL : 19.26 (+0.36%)
PAGP : 23.81 (+1.49%)
EGAN : 11.76 (+1.64%)
What Makes Bovie Medical (BVX) a Strong Momentum Stock: Buy Now?

Does Bovie Medical (BVX) have what it takes to be a top stock pick for momentum investors? Let's find out.

BVX : 6.48 (+1.09%)
Bovie Medical Corporation Reports Third Quarter 2018 Financial Results and Updates Fiscal Year 2018 Outlook

Bovie Medical Corporation (NYSEAMERICAN:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under...

BVX : 6.48 (+1.09%)
Zacks.com highlights: WillScot, Primerica, Bovie Medical, Shenandoah Telecommunications and Herbalife Nutrition

Zacks.com highlights: WillScot, Primerica, Bovie Medical, Shenandoah Telecommunications and Herbalife Nutrition

HLF : 56.75 (+1.10%)
BVX : 6.48 (+1.09%)
WSC : 10.39 (-0.48%)
PRI : 123.07 (+1.38%)
SHEN : 49.62 (-1.61%)
Snap Up These 5 Stocks on New Analyst Coverage

Increased analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.

HLF : 56.75 (+1.10%)
BVX : 6.48 (+1.09%)
WSC : 10.39 (-0.48%)
PRI : 123.07 (+1.38%)
SHEN : 49.62 (-1.61%)
Bovie Medical Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 14, 2018 / Bovie Medical Corporation (NYSE American: ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 14, 2018 at 4:30 PM Eastern...

BVX : 6.48 (+1.09%)
Bovie Medical Corporation Announces Completion of Enrollment in J-Plasma(R)/Renuvion(TM) Dermal Resurfacing Study

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under the...

BVX : 6.48 (+1.09%)
Bovie Medical Corporation Announces Appointment of Diane I. Duncan, M.D., FACS to Medical Advisory Board

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under the...

BVX : 6.48 (+1.09%)
Bovie Medical Corporation to Release First Quarter of Fiscal Year 2018 Financial Results on May 14, 2018

Bovie Medical (NYSE: BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, today announced that financial results for the first...

BVX : 6.48 (+1.09%)

Van Meerten Stock Picks

SecureWorks - Pick of the Day
My Stock Pick of the Day belongs to the security software company SecureWorks (SCWX).
SCWX +0.11
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar